Heparin-binding proteins and extracellular matrix components (HBP/ECM)

Heparin-binding proteins (HBPs) and extracellular matrix (ECM) components represent a broad and heterogeneous class of molecules that are fundamental to tissue structure and cellular signaling. HBPs include a wide array of growth factors, such as Vascular Endothelial Growth Factor (VEGF) and Fibroblast Growth Factors (FGFs), as well as cytokines and enzymes that exhibit high affinity for heparin and heparan sulfate proteoglycans (HSPGs) (Ori et al., 2011, Frontiers in Bioscience). The ECM acts as a dynamic scaffold that sequesters these HBPs, regulating their stability, distribution, and interaction with cell-surface receptors (Lu et al., 2012, Journal of Cell Biology). In pathological conditions like cancer, the ECM undergoes significant remodeling, and the dysregulated release of HBPs promotes tumor growth, angiogenesis, and metastasis (Fuster & Wang, 2010, Nature Reviews Drug Discovery). Furthermore, specific HBPs like Azurocidin serve as critical mediators and biomarkers in inflammatory states such as sepsis (Linder et al., 2009, Critical Care Medicine). Therapeutic strategies targeting this system often utilize heparin mimetics to displace HBPs or monoclonal antibodies to neutralize specific components, thereby modulating biological pathways involved in coagulation, inflammation, and tissue repair.

Other names

Heparin-binding growth factorsExtracellular matrix proteinsHeparin-binding proteoglycansHBP/ECM components

Competitive inhibition of heparin-binding domains, sequestration of growth factors to prevent receptor activation, and enzymatic modulation of extracellular matrix remodeling.